Emergent BioSolutions Inc.
US ˙ NYSE ˙ US29089Q1058

SecurityEBS / Emergent BioSolutions Inc.
InstitutionAperio Group, LLC
Latest Disclosed Ownership24,560 shares
Latest Disclosed Value $ 2,201,000
Aperio Group, LLC reports 26.63% decrease in ownership of EBS / Emergent BioSolutions Inc.

On February 5, 2021 - Aperio Group, LLC filed a 13F-HR form disclosing ownership of 24,560 shares of Emergent BioSolutions Inc. (US:EBS) valued at $2,200,576 USD as of December 31, 2020. The entity filed a previous 13F-HR on November 6, 2020 disclosing 33,473 shares of Emergent BioSolutions Inc.. This represents a change in shares of -26.63% during the quarter. The current value of the position is $198,199 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2021-02-05 2020-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 24,560 -8,913 -26.63 2,201 -36.37 0.0065
2020-11-06 2020-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 33,473 9,684 40.71 3,459 83.89 0.0117
2020-08-13 2020-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 23,789 1,190 5.27 1,881 43.81 0.0069
2020-05-05 2020-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 22,599 1,788 8.59 1,308 16.47 0.0058
2020-02-13 2019-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 20,811 1,226 6.26 1,123 9.67 0.0040
2019-11-06 2019-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 19,585 1,583 8.79 1,024 17.70 0.0040
2019-07-30 2019-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 18,002 -1,508 -7.73 870 -11.76 0.0036
2019-05-13 2019-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 19,510 -888 -4.35 986 -18.44 0.0043
2019-05-06 2018-12-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 20,398 4,405 27.54 1,209 14.81 0.0061
2019-02-14 2018-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 19,567 3,574 1,160
2019-05-06 2018-09-30 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 15,993 822 5.42 1,053 37.47 0.0046
2018-10-17 2018-09-30 13F EMERGENT BIOSOLUTIONS COMMON 29089Q105 15,993 822 1,053
2019-05-06 2018-06-30 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 15,171 366 2.47 766 -1.67 0.0037
2018-07-30 2018-06-30 13F EMERGENT BIOSOLUTIONS COMMON 29089Q105 15,171 366 766
2019-05-01 2018-03-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 14,805 1,497 11.25 779 26.05 0.0039
2018-05-08 2018-03-31 13F EMERGENT BIOSOLUTIONS COMMON 29089Q105 14,805 1,497 779
2019-05-01 2017-12-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 13,308 465 3.62 618 19.08 0.0032
2018-02-02 2017-12-31 13F EMERGENT BIOSOLUTIONS COMMON 29089Q105 13,308 465 618
2019-05-01 2017-09-30 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 12,843 1,199 10.30 519 31.39 0.0029
2017-10-25 2017-09-30 13F EMERGENT BIOSOLUTIONS COMMON 29089Q105 12,843 1,199 519
2019-04-22 2017-06-30 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 11,644 589 5.33 395 23.05 0.0024
2017-07-18 2017-06-30 13F EMERGENT BIOSOLUTIONS COMMON 29089Q105 11,644 589 395
2019-04-22 2017-03-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 11,055 -592 -5.08 321 -15.97 0.0022
2017-05-05 2017-03-31 13F EMERGENT BIOSOLUTIONS COMMON 29089Q105 11,055 -592 321
2019-04-22 2016-12-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 11,647 1,680 16.86 382 21.66 0.0029
2017-02-14 2016-12-31 13F EMERGENT BIOSOLUTIONS COMMON 29089Q105 11,647 1,680 382
2019-04-12 2016-09-30 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 9,967 -1,358 -11.99 314 -1.26 0.0023
2016-11-01 2016-09-30 13F EMERGENT BIOSOLUTIONS COMMON 29089Q105 9,967 -1,358 314
2019-04-12 2016-06-30 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 11,325 783 7.43 318 -16.97 0.0025
2016-08-12 2016-06-30 13F EMERGENT BIOSOLUTIONS COMMON 29089Q105 11,325 783 318
2019-04-12 2016-03-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 10,542 2,154 25.68 383 13.99 0.0033
2016-04-28 2016-03-31 13F EMERGENT BIOSOLUTIONS COMMON 29089Q105 10,542 2,154 383
2016-01-21 2015-12-31 13F EMERGENT BIOSOLUTIONS COMMON 29089Q105 8,388 1,090 14.94 336 61.54 0.0031
2015-10-19 2015-09-30 13F EMERGENT BIOSOLUTIONS COMMON 29089Q105 7,298 981 15.53 208 0.00 0.0021
2015-07-29 2015-06-30 13F EMERGENT BIOSOLUTIONS COMMON 29089Q105 6,317 208
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.